Silverback Therapeutics Inc
NASDAQ:SBTX
Cash Flow Statement
Cash Flow Statement
Silverback Therapeutics Inc
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Operating Cash Flow | ||||
Net Income |
(33)
|
(89)
|
(35)
|
|
Depreciation & Amortization |
1
|
1
|
0
|
|
Other Non-Cash Items |
4
|
20
|
7
|
|
Cash Interest Paid |
0
|
0
|
0
|
|
Change in Working Capital |
(3)
|
2
|
(13)
|
|
Cash from Operating Activities |
(31)
N/A
|
(67)
-114%
|
(40)
+40%
|
|
Investing Cash Flow | ||||
Capital Expenditures |
(1)
|
(1)
|
(0)
|
|
Other Items |
0
|
(65)
|
0
|
|
Cash from Investing Activities |
(1)
N/A
|
(66)
-7 150%
|
(0)
+100%
|
|
Financing Cash Flow | ||||
Net Issuance of Common Stock |
412
|
1
|
1
|
|
Net Issuance of Debt |
(1)
|
(1)
|
(9)
|
|
Other |
(3)
|
0
|
199
|
|
Cash from Financing Activities |
409
N/A
|
1
-100%
|
191
+30 964%
|
|
Change in Cash | ||||
Net Change in Cash |
376
N/A
|
(133)
N/A
|
150
N/A
|
|
Free Cash Flow | ||||
Free Cash Flow |
(32)
N/A
|
(68)
-112%
|
(40)
+41%
|